Gum disease: radical treatment improves life quality in diabetics

Gum disease: radical treatment improves life quality in diabetics

Gum disease affects almost half of the UK population and people with diabetes have a higher risk of developing it. Gum disease sets in when the levels of bacteria inside the mouth are out of balance, and it causes chronic inflammation inside the body. This inflammation has been linked to cardiovascular and kidney complications, as well as insulin resistance. A study funded by Diabetes UK has found that treating periodontitis (gum disease) could help people with Type 2 diabetes manage their blood glucose levels, and may reduce their risk of diabetes-related complications. The findings, published in The Lancet Diabetes and Endocrinology, are the first to link intensive gum disease treatment to improvements in kidney and blood vessel function and chronic inflammation. While more research is needed to explore this connection, the findings suggest that treatment may help to reduce the risk of serious diabetes-related complications, such as heart disease, stroke and kidney disease, in people with Type 2 diabetes. Researchers at the UCL Eastman Dental Institute recruited 264 people with type 2 diabetes, all of whom had moderate to severe periodontitis.

Half of the participants received intensive treatment for their gum disease, which involved deep cleaning their gums and minor gum surgery. The other half received standard care, involving regular cleaning and polishing of their teeth. The treatments were provided alongside any type 2 diabetes medications being taken. After 12 months, participants receiving the intensive treatment had reduced their blood glucose levels (HbA1c) by on average 0.6 per cent more than the standard care group. This suggests that intensive gum disease treatment could help some people with Type 2 diabetes to improve their blood glucose levels. The researchers also observed a link between the treatment and improved quality of life. Inflammation may be part of the biological pathways that lead to several health conditions including diabetes, heart disease, dementia and cancer. The findings that reduction in periodontitis, which is a common cause of inflammation, improves vascular, renal, as well as blood glucose control, in people with type 2 diabetes, are exciting and could lead to new strategies to improve care. Currently people with type 2 diabetes aren’t given oral health advice or treatment as part of their routine diabetes care. 

While more work is needed to fully understand how good oral health could help with blood glucose management, this research gives us important insights into the potential benefits of looking after your oral health if you have type 2 diabetes. Professor Francesco D’Aiuto, lead researcher of the study, said: “Our findings suggest preventing and treating gum disease could potentially be a new and important way to help people with Type 2 diabetes manage their condition, and reduce their risk of its serious complications. The improvement in blood glucose control we observed, in people who received intensive treatment, is similar to the effect that’s seen when people with Type 2 diabetes are prescribed a second blood glucose lowering drug. Large-scale clinical outcome trials should now be designed. We now need to determine if the improvements we found can be maintained in the longer-term and if they apply to everyone with type 2 diabetes”.

  • edited by Dr. Gianfrancesco Cormaci, PhD, specialista in Biochimica Clinica.

Scientific references

Suvan JE et al., D’Aiuto F. Periodontol 2000. 2018; 78:98-128.

Graves DT et al. J Dent Res. 2018 Oct 25: 22034518805739.

Vergnes JN et al. J Clin Periodontol. 2018; 45(10):1150-1163.

Nibali L et al. J Periodontal Res. 2015 Dec; 50(6):890-896. 

Informazioni su Dott. Gianfrancesco Cormaci 1069 Articoli
- Laurea in Medicina e Chirurgia nel 1998 (MD Degree in 1998) - Specialista in Biochimica Clinica nel 2002 (Clinical Biochemistry specialty in 2002) - Dottorato in Neurobiologia nel 2006 (Neurobiology PhD in 2006) - Ha soggiornato negli Stati Uniti, Baltimora (MD) come ricercatore alle dipendenze del National Institute on Drug Abuse (NIDA/NIH) e poi alla Johns Hopkins University, dal 2004 al 2008. - Dal 2009 si occupa di Medicina personalizzata. - Detentore di un brevetto sulla preparazione di prodotti gluten-free a partire da regolare farina di frumento immunologicamente neutralizzata (owner of a patent concerning the production of bakery gluten-free products, starting from regular wheat flour). - Autore di un libro riguardante la salute e l'alimentazione, con approfondimenti su come questa condizioni tutti i sistemi corporei. - Autore di articoli su informazione medica, salute e benessere sui siti web salutesicilia.com e medicomunicare.it